Tumor expression of adiponectin receptor 2 and lethal prostate cancer

Jennifer R. Rider, Michelangelo Fiorentino, Rachel Kelly, Travis Gerke, Kristina Jordahl, Jennifer A. Sinnott, Edward L. Giovannucci, Massimo Loda, Lorelei A. Mucci, Stephen Finn, Transdisciplinary Prostate Cancer Partnership (ToPCaP)


To investigate the role of adiponectin receptor 2 (AdipoR2) in aggressive prostate cancer we used immunohistochemistry to characterize AdipoR2 protein expression in tumor tissue for 866 men with prostate cancer from the Physicians’ Health Study and the Health Professionals Follow-up Study. AdipoR2 tumor expression was not associated with measures of obesity, pathological tumor stage or prostate-specific antigen (PSA) at diagnosis. However, AdipoR2 expression was positively associated with proliferation as measured by Ki-67 expression quartiles (P-trend < 0.0001), with expression of fatty acid synthase (P-trend = 0.001), and with two measures of angiogenesis (P-trend < 0.1). An inverse association was observed with apoptosis as assessed by the TUNEL assay (P-trend = 0.006). Using Cox proportional hazards regression and controlling for age at diagnosis, Gleason score, year of diagnosis category, cohort and baseline BMI, we identified a statistically significant trend for the association between quartile of AdipoR2 expression and lethal prostate cancer (P-trend = 0.02). The hazard ratio for lethal prostate cancer for the two highest quartiles, as compared to the two lowest quartiles, of AdipoR2 expression was 1.9 (95% confidence interval [CI]: 1.2-3.0). Results were similar when additionally controlling for categories of PSA at diagnosis and Ki-67 expression quartiles. These results strengthen the evidence for the role of AdipoR2 in prostate cancer progression.

Published In Carcinogenesis
Date Apr 11, 2015
DOI 10.1093/carcin/bgv048


Rider JR, Fiorentino M, Kelly R, Gerke TA, Jordahl K, Sinnott JA, Giovannucci EL, Loda MF, Mucci LA, Finn S. Tumor expression of Adiponectin Receptor 2 and lethal prostate cancer. Carcinogenesis 2015; 36(6): 639--647. PMID: 25863129. PMCID: PMC4481603.